Fluid Biopsy Market Size, Trends, Analysis, and Outlook By Indication (Lung Cancer, Breast Cancer, Colorectal, Others), By Type (Circulating Tumor Cells, Circulating Tumor DNA, Cell-free DNA), by Country, Segment, and Companies, 2024-2032
The global Fluid Biopsy market size is poised to register 14.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Fluid Biopsy market across By Indication (Lung Cancer, Breast Cancer, Colorectal, Others), By Type (Circulating Tumor Cells, Circulating Tumor DNA, Cell-free DNA)
With the increasing emphasis on minimally invasive cancer diagnostics and precision oncology and the growing demand for liquid biopsy tests that offer non-invasive and real-time assessment of tumor-derived biomarkers in blood, urine, and other body fluids, there is a rising adoption of fluid biopsy technologies that enable early cancer detection, treatment monitoring, and therapy guidance in cancer patients. Market growth is driven by factors such as expanding oncology market, rising cancer incidence and mortality rates, and advancements in molecular diagnostics and next-generation sequencing (NGS) for sensitive and specific detection of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and extracellular vesicles (EVs) in liquid biopsy specimens. Additionally, the expanding applications of fluid biopsy in cancer screening, minimal residual disease (MRD) detection, and treatment response assessment, as well as the development of multi-analyte liquid biopsy panels and machine learning algorithms for comprehensive cancer profiling and predictive biomarker discovery, contribute to market expansion. Further, the emphasis on liquid biopsy test validation, standardization, and regulatory approval in oncology clinical trials and patient care pathways, along with efforts to integrate liquid biopsy data with electronic health records (EHRs) and clinical decision support systems for precision cancer medicine and personalized therapy optimization, is expected to further accelerate market growth in the coming years.
Fluid Biopsy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Fluid Biopsy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Fluid Biopsy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Fluid Biopsy industry.
Key market trends defining the global Fluid Biopsy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Fluid Biopsy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Fluid Biopsy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Fluid Biopsy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Fluid Biopsy industry
Leading Fluid Biopsy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Fluid Biopsy companies.
Fluid Biopsy Market Study- Strategic Analysis Review
The Fluid Biopsy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Fluid Biopsy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Fluid Biopsy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Fluid Biopsy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Fluid Biopsy market segments. Similarly, Strong market demand is encouraging Canadian Fluid Biopsy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Fluid Biopsy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Fluid Biopsy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Fluid Biopsy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Fluid Biopsy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Fluid Biopsy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Fluid Biopsy in Asia Pacific. In particular, China, India, and South East Asian Fluid Biopsy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Fluid Biopsy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Fluid Biopsy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Fluid Biopsy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Fluid Biopsy.
Fluid Biopsy Market Company Profiles
The global Fluid Biopsy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Bio-Rad Laboratories Inc, Diagnologix LLC, Exosome Sciences Inc, GRAIL Inc, Guardant Health Inc, Horizon Discovery Group plc, Illumina Inc, Inivata Ltd, Lucence Diagnostics Pte Ltd, LungLife AI Inc, Predicine Inc, QIAGEN N.V.
Recent Fluid Biopsy Market Developments
The global Fluid Biopsy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Fluid Biopsy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Indication
Lung Cancer
Breast Cancer
Colorectal
Others
By Type
Circulating Tumor Cells
Circulating Tumor DNA
Cell-free DNA
Geographical Segmentation:
Bio-Rad Laboratories Inc
Diagnologix LLC
Exosome Sciences Inc
GRAIL Inc
Guardant Health Inc
Horizon Discovery Group plc
Illumina Inc
Inivata Ltd
Lucence Diagnostics Pte Ltd
LungLife AI Inc
Predicine Inc
QIAGEN N.V.
Formats Available: Excel, PDF, and PPT
With the increasing emphasis on minimally invasive cancer diagnostics and precision oncology and the growing demand for liquid biopsy tests that offer non-invasive and real-time assessment of tumor-derived biomarkers in blood, urine, and other body fluids, there is a rising adoption of fluid biopsy technologies that enable early cancer detection, treatment monitoring, and therapy guidance in cancer patients. Market growth is driven by factors such as expanding oncology market, rising cancer incidence and mortality rates, and advancements in molecular diagnostics and next-generation sequencing (NGS) for sensitive and specific detection of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and extracellular vesicles (EVs) in liquid biopsy specimens. Additionally, the expanding applications of fluid biopsy in cancer screening, minimal residual disease (MRD) detection, and treatment response assessment, as well as the development of multi-analyte liquid biopsy panels and machine learning algorithms for comprehensive cancer profiling and predictive biomarker discovery, contribute to market expansion. Further, the emphasis on liquid biopsy test validation, standardization, and regulatory approval in oncology clinical trials and patient care pathways, along with efforts to integrate liquid biopsy data with electronic health records (EHRs) and clinical decision support systems for precision cancer medicine and personalized therapy optimization, is expected to further accelerate market growth in the coming years.
Fluid Biopsy Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Fluid Biopsy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Fluid Biopsy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Fluid Biopsy industry.
Key market trends defining the global Fluid Biopsy demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Fluid Biopsy Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Fluid Biopsy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Fluid Biopsy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Fluid Biopsy industry
Leading Fluid Biopsy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Fluid Biopsy companies.
Fluid Biopsy Market Study- Strategic Analysis Review
The Fluid Biopsy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Fluid Biopsy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Fluid Biopsy Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Fluid Biopsy Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Fluid Biopsy market segments. Similarly, Strong market demand is encouraging Canadian Fluid Biopsy companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Fluid Biopsy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Fluid Biopsy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Fluid Biopsy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Fluid Biopsy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Fluid Biopsy Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Fluid Biopsy in Asia Pacific. In particular, China, India, and South East Asian Fluid Biopsy markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Fluid Biopsy Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Fluid Biopsy Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Fluid Biopsy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Fluid Biopsy.
Fluid Biopsy Market Company Profiles
The global Fluid Biopsy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Bio-Rad Laboratories Inc, Diagnologix LLC, Exosome Sciences Inc, GRAIL Inc, Guardant Health Inc, Horizon Discovery Group plc, Illumina Inc, Inivata Ltd, Lucence Diagnostics Pte Ltd, LungLife AI Inc, Predicine Inc, QIAGEN N.V.
Recent Fluid Biopsy Market Developments
The global Fluid Biopsy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Fluid Biopsy Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Indication
Lung Cancer
Breast Cancer
Colorectal
Others
By Type
Circulating Tumor Cells
Circulating Tumor DNA
Cell-free DNA
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Bio-Rad Laboratories Inc
Diagnologix LLC
Exosome Sciences Inc
GRAIL Inc
Guardant Health Inc
Horizon Discovery Group plc
Illumina Inc
Inivata Ltd
Lucence Diagnostics Pte Ltd
LungLife AI Inc
Predicine Inc
QIAGEN N.V.
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Fluid Biopsy Market Overview and Key Findings, 2024
1.2 Fluid Biopsy Market Size and Growth Outlook, 2021- 2030
1.3 Fluid Biopsy Market Growth Opportunities to 2030
1.4 Key Fluid Biopsy Market Trends and Challenges
1.4.1 Fluid Biopsy Market Drivers and Trends
1.4.2 Fluid Biopsy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Fluid Biopsy Companies
2. FLUID BIOPSY MARKET SIZE OUTLOOK TO 2030
2.1 Fluid Biopsy Market Size Outlook, USD Million, 2021- 2030
2.2 Fluid Biopsy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. FLUID BIOPSY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. FLUID BIOPSY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Indication
Lung Cancer
Breast Cancer
Colorectal
Others
By Type
Circulating Tumor Cells
Circulating Tumor DNA
Cell-free DNA
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Fluid Biopsy Market, 2025
5.2 Asia Pacific Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Fluid Biopsy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Fluid Biopsy Market, 2025
5.5 Europe Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.6 Europe Fluid Biopsy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Fluid Biopsy Market, 2025
5.8 North America Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.9 North America Fluid Biopsy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Fluid Biopsy Market, 2025
5.11 South America Pacific Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.12 South America Fluid Biopsy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Fluid Biopsy Market, 2025
5.14 Middle East Africa Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Fluid Biopsy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Fluid Biopsy Market Size Outlook and Revenue Growth Forecasts
6.2 US Fluid Biopsy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Fluid Biopsy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Fluid Biopsy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Fluid Biopsy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Fluid Biopsy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Fluid Biopsy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Fluid Biopsy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Fluid Biopsy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Fluid Biopsy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Fluid Biopsy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Fluid Biopsy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Fluid Biopsy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Fluid Biopsy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Fluid Biopsy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Fluid Biopsy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Fluid Biopsy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Fluid Biopsy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Fluid Biopsy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Fluid Biopsy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Fluid Biopsy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Fluid Biopsy Industry Drivers and Opportunities
7. FLUID BIOPSY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. FLUID BIOPSY COMPANY PROFILES
8.1 Profiles of Leading Fluid Biopsy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Bio-Rad Laboratories Inc
Diagnologix LLC
Exosome Sciences Inc
GRAIL Inc
Guardant Health Inc
Horizon Discovery Group plc
Illumina Inc
Inivata Ltd
Lucence Diagnostics Pte Ltd
LungLife AI Inc
Predicine Inc
QIAGEN N.V..
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Fluid Biopsy Market Overview and Key Findings, 2024
1.2 Fluid Biopsy Market Size and Growth Outlook, 2021- 2030
1.3 Fluid Biopsy Market Growth Opportunities to 2030
1.4 Key Fluid Biopsy Market Trends and Challenges
1.4.1 Fluid Biopsy Market Drivers and Trends
1.4.2 Fluid Biopsy Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Fluid Biopsy Companies
2. FLUID BIOPSY MARKET SIZE OUTLOOK TO 2030
2.1 Fluid Biopsy Market Size Outlook, USD Million, 2021- 2030
2.2 Fluid Biopsy Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. FLUID BIOPSY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. FLUID BIOPSY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Indication
Lung Cancer
Breast Cancer
Colorectal
Others
By Type
Circulating Tumor Cells
Circulating Tumor DNA
Cell-free DNA
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Fluid Biopsy Market, 2025
5.2 Asia Pacific Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Fluid Biopsy Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Fluid Biopsy Market, 2025
5.5 Europe Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.6 Europe Fluid Biopsy Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Fluid Biopsy Market, 2025
5.8 North America Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.9 North America Fluid Biopsy Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Fluid Biopsy Market, 2025
5.11 South America Pacific Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.12 South America Fluid Biopsy Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Fluid Biopsy Market, 2025
5.14 Middle East Africa Fluid Biopsy Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Fluid Biopsy Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Fluid Biopsy Market Size Outlook and Revenue Growth Forecasts
6.2 US Fluid Biopsy Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Fluid Biopsy Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Fluid Biopsy Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Fluid Biopsy Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Fluid Biopsy Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Fluid Biopsy Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Fluid Biopsy Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Fluid Biopsy Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Fluid Biopsy Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Fluid Biopsy Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Fluid Biopsy Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Fluid Biopsy Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Fluid Biopsy Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Fluid Biopsy Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Fluid Biopsy Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Fluid Biopsy Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Fluid Biopsy Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Fluid Biopsy Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Fluid Biopsy Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Fluid Biopsy Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Fluid Biopsy Industry Drivers and Opportunities
7. FLUID BIOPSY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. FLUID BIOPSY COMPANY PROFILES
8.1 Profiles of Leading Fluid Biopsy Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Bio-Rad Laboratories Inc
Diagnologix LLC
Exosome Sciences Inc
GRAIL Inc
Guardant Health Inc
Horizon Discovery Group plc
Illumina Inc
Inivata Ltd
Lucence Diagnostics Pte Ltd
LungLife AI Inc
Predicine Inc
QIAGEN N.V..
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
